Opsonophagocytosis versus complement bactericidal killing as effectors following Neisseria meningitidis group C vaccination

Infection

Volumn 31, Issue 1, 2003, Pages 51-54

  Gomez Lus, M L ^a   Gimenez M J ^b   Vazquez J A ^c   Aguilar, L ^b   Anta, L ^a   Berron S ^c   Laguna, B ^a   Prieto, J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b GLAXOSMITHKLINE   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; COMPLEMENT; MENCEVAX A C; MENINGOCOCCUS VACCINE; POLYSACCHARIDE A C VACCINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERICIDAL ACTIVITY; HUMAN; HUMAN EXPERIMENT; IMMUNOREGULATION; INOCULATION; MALE; MENINGITIS; NEISSERIA MENINGITIDIS; NORMAL HUMAN; OPSONOPHAGOCYTOSIS; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PROPHYLAXIS; SINGLE DRUG DOSE; VACCINATION;

BLOOD BACTERICIDAL ACTIVITY; COMPLEMENT SYSTEM PROTEINS; HUMANS; MALE; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP C; OPSONIN PROTEINS; PHAGOCYTOSIS; SEROLOGIC TESTS; TIME FACTORS;

EID: 12244257524     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-002-3128-4     Document Type: Article

References (17)

1. Goldschneider I, Gotschlich EC, Artenstein MS: Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med. 1969; 129: 1327-1328.
2. Apicella MA:. Neisseria meningitidis. In: Mandell GL, Bennett JE, Dolin R (eds): Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia 2000, pp 2228-2241.
3. Lepow ML, Perkins BA, Hughes PA, Poolman JT. Meningococcal vaccines. In: Plotkin SA, Orenstein WA (eds):Vaccines. W.B. Saunders, Philadelphia 1999, pp 711-727.
4. Gheesling LL, Carlone GM, Pais LB, Holder PF, Maslanka SE, Plikaytis BD, Achtman M, Densen P, Frasch CE, Kayhty H, Mays JR, Nencioni L, Peeters C, Phipps DC, Poolman JT, Rosenqvist E, Siber GR, Thiesen B, Tai J, Thompson CM, Vella PP, Wenger JD. Multicenter comparison of Neisseria meningitidis serogroup C anticapsular polysaccharide antibody levels measured by a standardized enzymelinked immunosorbent assay. J Clin Microbiol 1994; 32: 1475-1482.
5. Schlesinger M, Greenberg R, Levy J, Kayhty H, Levy R: Killing of meningococci by neutrophils: effect of vaccination on patients with complement deficiency. J Infect Dis 1994; 170: 449-453.
6. Sjursen H, Bjerknes R, Halstensen A, Naess A, Froholm LO, Rosenqvist E, Solberg CO: Serum opsonins to group B meningococci. Acta Pathol Microbiol Scand (C) 1987; 95: 283-289.
7. Zangwill KM, Stout RW, Carlone GM, Pais L, Harekeh H, Mitchell S, Wolfe WH, Blackwood V, Plikaytis BD, Wenger JD: Duration of antibody response after meningococcal polysaccharide vaccination US Air Force personnel. J Infect Dis 1994; 169: 847-852.
8. Aase A, Bjune G, Hoiby EA, Rosenqvist E, Pedersen AK, Michaelsen TE: Comparison among opsonic activity, anti-meningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccines after immunization with a serogroup B outer membrane vesicle vaccine. Infect Immun 1995; 63: 3531-3536.
9. Naess LM, Aarvak T, Aase A, Oftung F, Hoiby EA, Sandin R, Michaelsen TE: Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine. Vaccine 1999; 17: 754-764.
10. Gómez-Lus ML, Aguilar L, Vázquez J, Giménez MJ, Ruiz G, Berrón S, Fuentes F, Prieto J: Ex vivo bactericidal activity against group C Neisseria meningitidis in seronegative subjects, Infection 2000; 28: 305-308.
11. Maslanka SE, Gheesling LL, Libutti DE, Donaldson KB, Harakeh HS, Dykes JK, Arhin FF, Devi SJ, Frasch CE, Huang JC, Kriz-Kuzemenska P, Lemmon BD, Lorange M, Peeters CC, Quataert S, Tai JY, Carlone GM: Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group. Clin Diagn Lab Immunol 1997; 4: 156-167.
12. Lepow ML: Meningococcal vaccines In: Plotking SA, Mortimer EA (eds): Vaccines. W.B Saunders, Philadelphia 1994, pp 503-516.
13. Lepow ML, Goldschneider I, Gold R, Randolph M, Gotschlich EC: Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines. Pediatrics 1977; 60: 673-680.
14. Eggleton P, Gargan R, Fisher D: Rapid method for the isolation of neutrophils in high yield without the use of dextran or density gradient polymers. J Immunol Methods. 1989; 121: 105-113.
15. Gold R, Artenstein MS: Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70. Bull World Health Organ 1971; 45: 279-282.
16. Carlone GM, Wenger JD, Perkins BA, Maslanka, SE, Popovic T: Haemophilus influenzae type b, Neisseria meningitidis, Streptococcus pneumoniae, and Corynebacteriurn diphtheriae vaccines. In: Rose NR, Conway de Macario E, Folds JD, Lane HG, Nakamura RM (eds): Manual of Clinical Laboratory Immunology. ASM Press, Washington DC 1997, PP 458-469.
17. Holder PK, Maslanka SE, Pais LB, Dykes J, Plikaytis BD, Carlone GM. Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992. Clin Diagn Lab Immunol 1995; 2: 132-137.